Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus

Publisher： Karger

E-ISSN： 1423-0100|47|6|362-369

ISSN： 0300-5526

Source： Intervirology, Vol.47, Iss.6, 2004-11, pp. : 362-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil

By  

Intervirology, Vol. 51, Iss. 6, 2009-02 ,pp. : 385-393

Karger

Access to resources Recommend Favorite

Prediction of Breakthrough Hepatitis due to Lamivudine-Resistant Hepatitis B Virus by a Sensitive Semiquantitative Assay Using Peptide Nucleic Acids

By  

Intervirology, Vol. 49, Iss. 5, 2006-08 ,pp. : 274-280

Karger

Access to resources Recommend Favorite

Subclones of Drug-Resistant Hepatitis B Virus Mutants and the Outcome of Breakthrough Hepatitis in Patients Treated with Lamivudine

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 350-354

Karger

Access to resources Recommend Favorite

Clearance of the original hepatitis B virus YMDD‐motif mutants with emergence of distinct lamivudine‐resistant mutants during prolonged lamivudine therapy

By  

HEPATOLOGY, Vol. 31, Iss. 6, 2000-06 ,pp. : 1318-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite